THE LANCET HAEMATOLOGY

Visão geral
Metrics
Identidade
Ver todos

Qualis

A1

código do país

NL

tipo

journal

publicação venue de

Association between maternal haemoglobin concentrations and maternal and neonatal outcomes: the prospective, observational, multinational, INTERBIO-21st fetal study. Online:Online first. 2023-01-01
Barriers in the diagnosis of pulmonary embolism. 10:e11. 2023-01-01
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission. 17-70. 2023-01-01
Endemic or regionally limited bacterial and viral infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. 10:e284-e294. 2023-01-01
Endemic or regionally limited parasitic and fungal infections in haematopoietic stem-cell transplantation recipients: a Worldwide Network for Blood and Marrow Transplantation (WBMT) Review. 10:e295-e305. 2023-01-01
Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021. 10:e585-e599. 2023-01-01
Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990?2021: findings from the Global Burden of Disease Study 2021. 23:S2352. 2023-01-01
Development of an international standard set of outcome measures for patients with venous thromboembolism: an International Consortium for Health Outcomes Measurement consensus recommendation. 9:e698-e706. 2022-01-01
From residency training to professional life: which competencies and skills are most valued by haematologists in Brazil?. 9:e95-e96. 2022-01-01
Mitapivat for treatment of pyruvate kinase deficiency. 9:e708-e709. 2022-01-01
Transplantation for Fanconi anaemia: lessons learned from Brazil. 9:e228-e236. 2022-01-01
Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. 8:e22-e33. 2021-01-01
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. 7:e18-e27. 2020-01-01
Subcutaneous versus intravenous daratumumab in patients with relapsed or refractory multiple myeloma (COLUMBA): a multicentre, open-label, non-inferiority, randomised, phase 3 trial. 7:e370-e380. 2020-01-01
Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project. 7:e284-e294. 2020-01-01
Survival outcomes of patients with extranodal natural-killer TCell lymphoma: a prospective cohort study from the international TCell Project.. 2:2352-3026. 2020-01-01
The role of haematopoietic stem cell transplantation for sickle cell disease in the era of targeted disease-modifying therapies and gene editing. 7:e902-e911. 2020-01-01

tem uma área de assunto

publisher

Elsevier BV

is open access

False invalid format

is in DOAJ

False invalid format